All In Biotech

Investigational drug · Phase 2

HS-20110

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for CRC.

Phase 2

Last checked: Nov 19, 2026Latest source record: May 1, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

2

Any phase or sponsor naming "HS-20110"

First trial start

2025

Dec 22, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "HS-20110", any sponsor or status.

Conditions studied

As listed on its trial records.

  • CRC

Largest trials

Live from ClinicalTrials.gov: studies naming "HS-20110" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for CRC

  • GFH276Phase 25 trials

    Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)

  • RMC-9805Phase 23 trials

    Revolution Medicines, Inc. · PDAC, Colorectal Cancer, CRC

  • Tmod CAR T-cell TherapyA2B530, A2B694Phase 23 trials

    A2 Biotherapeutics Inc. · Solid Tumor, Adult, Colorectal Cancer, Colorectal Adenocarcinoma

  • OnvansertibPhase 22 trials

    Cardiff Oncology · Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation

  • TUB-030Phase 21 trial

    Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.